Englander Institute for Precision Medicine

Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation.

TitleCircular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation.
Publication TypeJournal Article
Year of Publication2025
AuthorsTeng M, Guo J, Xu X, Ci X, Mo Y, Kohen Y, Ni Z, Chen S, Guo WYuan, Bakht M, Ku S, Sigouros M, Luo W, Macarios CMaya, Xia Z, Chen M, Haq SUl, Yang W, Berlin A, van der Kwast T, Ellis L, Zoubeidi A, Zheng G, Ming J, Wang Y, Cui H, Lok BH, Raught B, Beltran H, Qin J, He HHansen
JournalCancer Cell
Date Published2025 Apr 17
ISSN1878-3686
Abstract

Circular RNA (circRNA) is a class of noncoding RNA with regulatory potentials. Its role in the transdifferentiation of prostate and lung adenocarcinoma into neuroendocrine prostate cancer (NEPC) and small cell lung cancer (SCLC) remains unexplored. Here, we identified circRMST as an exceptionally abundant circRNA predominantly expressed in NEPC and SCLC, with strong conservation between humans and mice. Functional studies using shRNA, siRNA, CRISPR-Cas13, and Cas9 consistently demonstrate that circRMST is essential for tumor growth and the expression of ASCL1, a master regulator of neuroendocrine fate. Genetic knockout of Rmst in NEPC genetic engineered mouse models prevents neuroendocrine transdifferentiation, maintaining tumors in an adenocarcinoma state. Mechanistically, circRMST physically interacts with lineage transcription factors NKX2-1 and SOX2. Loss of circRMST induces NKX2-1 protein degradation through autophagy-lysosomal pathway and alters the genomic binding of SOX2, collectively leading to the loss of ASCL1 transcription.

DOI10.1016/j.ccell.2025.03.027
Alternate JournalCancer Cell
PubMed ID40250444

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021